Polomar Health Services Return on Equity (ROE) Growth & History (PMHS)
Polomar Health Services's return on equity was −290.13% for fiscal 2025.
View full Polomar Health Services company overviewPolomar Health Services annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −290.13% | −258.77 pp |
| 2024 | 2024-12-31 | −31.36% | +795.45 pp |
| 2023 | 2023-12-31 | −826.81% | — |
Polomar Health Services quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2025 | 2025-12-31 | −274.71% | −266.69 pp |
| Q3 2025 | 2025-09-30 | −8.04% | −1.96 pp |
| Q2 2025 | 2025-06-30 | −7.32% | — |
| Q1 2025 | 2025-03-31 | −5.46% | — |
| Q4 2024 | 2024-12-31 | −8.02% | — |
| Q3 2024 | 2024-09-30 | −6.08% | +323.33 pp |
| Q3 2023 | 2023-09-30 | −329.41% | — |
| Q2 2023 | 2023-06-30 | −66.85% | — |
Polomar Health Services return on equity trends
Between the periods ended 2023-12-31 and 2025-12-31, Polomar Health Services's return on equity increased from −826.81% to −290.13%, a change of +536.68 percentage points. The latest reported quarter, Q4 2025, shows −274.71%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Polomar Health Services source filings ↗